BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program 
Immuron planned Acquisition of R&D Vaccine Company 
Todos Medical Launches Tollovid Daily™ via Subscription at MyTollovid.com 
SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections 
Surrozen Announces Appointment of Liz Nguyen as Vice President and Head of Human Resources 
DLH Wins FEMA Contract for COVID-19 Emergency Medical Services Throughout Alaska
ATLANTA, Sept. 23, 2021 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of...
electroCore to Participate at Upcoming Investor Conferences
ROCKAWAY, NJ, Sept. 23, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today...
Novan Reports Safety Data from B-SIMPLE4 Pivotal Phase 3 Study of SB206
– SB206 demonstrates continued favorable safety profile consistent with previous studies and meets Company’s expectations – – Pre-NDA meeting with...
Gain Therapeutics to Present at the Cantor Virtual Global Healthcare Conference
Conference Dates: September 27th-30thBETHESDA, Md., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”),...
Soleno Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
REDWOOD CITY, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing...
Frontier Medicines to Present at the Cantor Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock...
POINT Biopharma Announces Initiation of Randomization for its Phase 3 SPLASH study Evaluating PNT2002 for mCRPC
25 patient dosimetry and safety run-in met all pre-specified safety and efficacy criteria Initiated patient enrollment in Canada with additional...
Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-VVA1, Intravaginal Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy
Investigational therapy for women who cannot, or should not, take supplemental estrogen Potential to be the first treatment for vulvar...
BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com
BriaCell Therapeutics CEO Interview BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com AUSTIN, Texas, Sept. 23,...
Nanox to Present at the Cantor Fitzgerald Global Healthcare Conference
NEVE ILAN, Israel, Sept. 23, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative...